Claim Missing Document
Check
Articles

Found 3 Documents
Search
Journal : Majalah Obstetri dan Ginekologi

Risk factor of severe preeclampsia in Dr. Soetomo Hospital Surabaya in 2015 Amelia Rahmah Kartika; Muhammad Ilham Aldika Akbar; Pirlina Umiastuti
Majalah Obstetri dan Ginekologi Vol. 25 No. 1 (2017): April
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (172.08 KB) | DOI: 10.20473/mog.V25I12017.6-9

Abstract

Objectives: to determine which of the risk factors above associated with the occurrence of severe preeclampsia at dr. Soetomo Hospital, Surabaya during 2015.Materials and Methods: The type and design of the study were analytic and retrospective. This study was held in the dr. Soetomo Hospital from April until November 2016. The instrument of the study was the medical records then being coded and analysed. The samples were 134 pregnant women, consisting of 67 pregnant women with severe preeclampsia as cases and 67 pregnant women as controls.Results: Maternal obesity (OR= 5,786; 95% CI: 2,300–14,555), history of hypertension (OR= 6,693; 95% CI: 1,848–24,237) and secondary elderly primi (OR= 6,384; 95% CI: 1,357–30,031) are associated with the development of severe preeclampsia.Conclusion: In conclusion, the significant risk factors of severe preeclampsia in dr. Soetomo Hospital Surabaya during 2015 are obesity, history of hypertension and secondary elderly primi variables.
Difference of calcium levels in Javanese, Madurese, and Chinese preeclamptic women Nuzulul Azizah Ramdan Wulandari; Ernawati Ernawati; Muhammad Ilham Aldika Akbar
Majalah Obstetri dan Ginekologi Vol. 25 No. 3 (2017): December
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (92.045 KB) | DOI: 10.20473/mog.V25I32017.86-91

Abstract

Objectives: To analyse difference of calcium levels and charac-teristics between Javanese, Madurese, and Chinese pre-eclamptic women that affects preeclampsia incidence.Materials and Methods: This was a cross-sectional study with preeclamptic patients in Dr. Soetomo Hospital, Dr. M. Soewan-dhie Hospital, and Universitas Airlangga Hospital as sample. Sample was taken by measuring total calcium level in blood serum before receiving MgSO4 using in vitro clinical chemical dimension method in the Laboratory of Clinical Pathology in Dr. Soetomo Hospital. Sample was taken using consecutive sampling. Sample size 53 preeclamptic women as participants of this study, divided into three groups of Javanese, Madurese, and Chinese.Results: There were 53 preeclampsia patients, with mean ages: Javanese 31.21±5.76, Madurese 34.20±5.58, and Chinese 28.20 ±2.16. Mean BMI: Javanese 31.19±5.99, Madurese 27.66±4.74, and Chinese 26.24±2.13. We found significant difference in total calcium levels. In Madurese it was 7.7 mg/dL, Javanese was 8.3 mg/dL, and Chinese was 9.0 mg/dL (p=.000).Conclusion: The highest severity of preeclampsia was in the Madurese with low calcium levels. The lowest the calcium level, the worst the severity of the preeclampsia.
Is it time to start COVID-19 vaccination in pregnant women? Muhammad Ilham Aldika Akbar
Majalah Obstetri dan Ginekologi Vol. 29 No. 2 (2021): August
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/mog.V29I22021.84-90

Abstract

HIGHLIGHTS1. Pregnant women infected with COVID 19 have a higher risk of maternal fetal mortality and morbidity.2. The available evidences show a safety profile in all type of COVID vaccines in pregnancy.3. Vaccination in pregnant women will decrease pregnancy complications, adverse pregnancy outcomes, and maternal death risk.4. The benefit of COVID vaccination exceeds the potential risk in pregnant women.5. Pregnant women are strongly recommended to receive COVID vaccine. ABSTRACTCOVID-19 pandemic has been lasting for years, and pregnant women encounter an increased risk of mortality and morbidity. Until now, vaccine COVID-19 has been developed and shows a promising result. Unfortunately, pregnant women are consistently excluded from receiving a new vaccine. Because pregnant women are excluded from participating in a clinical trial of vaccines related to safety issues, this exclusion cycle prevents pregnant women from receiving the vaccine that may benefit them. In this review article, the author provides evidence, data, and the reason why vaccination of pregnant women should be started in Indonesia, at least in a clinical trial, especially for health workers and women with comorbidities.